Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print

Industry News

Related Searches:

Filter by:

March 11, 2010
Bio-Processing Alliance, Inc. (BPAI) has launched a biologics drug development consulting business to provide support the management of complex biologics programs from concept, through to development and Phase I-III trials.   Read More »
March 9, 2010
Exelixis, Inc. is restructuring as part of its continued strategy to focus resources on the development of its key late-stage compounds, XL184, XL147 and XL765.   Read More »
March 9, 2010
Almac has received the Aer Lingus Viscount Award for Overall Excellence. The annual award is given for contributing to the Northern Irish economy and improving business relationships between the UK and Ireland.   Read More »
March 8, 2010
Lilly has signed an agreement to acquire the European rights to a portfolio of certain Pfizer Animal Health products.   Read More »
March 8, 2010
The FDA has completed its inspection of Cell Therapeutics, Inc.’s (CTI) facility at NerPharMa, a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences in Nerviano, Italy.   Read More »
March 8, 2010
Quintiles has opened its expanded research facility in London, UK, increasing Phase I capacity and extending its capabilities in translational medicine.   Read More »
March 5, 2010
Anderson Packaging has received the International Quality and Productivity Centre (IQPC) excellence award in the small-to-mid-sized corporation category for the competition’s Best Process Improvement in a Manufacturing Project.   Read More »
March 4, 2010
Kendle received approval from Indian authorities to proceed with development of a new operations center in a Special Economic Zone (SEZ) in the Ahmedabad-Gandhinagar Knowledge Corridor.   Read More »
March 4, 2010
Watson Pharmaceuticals, Inc. entered an agreement to acquire exclusive U.S. rights to Columbia Laboratories, Inc.'s bioadhesive progesterone gel products currently marketed as Crinone and Prochieve for the indications of infertility and secondary amenorrh   Read More »
March 4, 2010
Congenix, a Moscow-based CRO, has become a certified member of Health Decisions’ Agile Clinical Network, a group of research partners formed to help eliminate the information gaps and prolonged timelines for complex global studies.   Read More »
March 3, 2010
First round of major R&D cuts at AstraZeneca includes dropping early research in many fields   Read More »
March 2, 2010
PPD enters European market with Athlone site   Read More »
March 2, 2010
Asterand adds to PhaseZERO suite of preclinical services   Read More »
March 1, 2010
Astellas Pharma has made an unsolicited bid of $3.5 billion in cash to buy all outstanding shares of OSI Pharma.   Read More »
March 1, 2010
AstraZeneca will exercise its option to buy out Merck's interest in AZ's non-PPI products for $647 million.   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On